0.40
price down icon0.50%   -0.002
after-market Handel nachbörslich: .41 0.010 +2.50%
loading

Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten

pulisher
May 25, 2026

SCNX Q1 2026 Earnings: Significant EPS Beat Despite Lack of RevenueNet Income Trends - Newser

May 25, 2026
pulisher
May 23, 2026

Scienture Holdings Reports 449% Revenue Growth and 95.6% Gross Margin Expansion in Q1 2026, Driven by Arbli and REZENOPY Launches - Minichart

May 23, 2026
pulisher
May 23, 2026

Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise - Newser

May 23, 2026
pulisher
May 22, 2026

Scienture Holdings (SCNX) Faces Selling Pressure Near Key Support LevelViral Trade Signals - Newser

May 22, 2026
pulisher
May 22, 2026

Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline and Operational ProgressViral Trade Signals - Newser

May 22, 2026
pulisher
May 21, 2026

Trxade Health announces name change to Scienture Holdings - Intellectia AI

May 21, 2026
pulisher
May 21, 2026

MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

May 21, 2026
pulisher
May 21, 2026

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI

May 21, 2026
pulisher
May 21, 2026

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI

May 21, 2026
pulisher
May 21, 2026

MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI

May 21, 2026
pulisher
May 20, 2026

MEDS News & Events - Intellectia AI

May 20, 2026
pulisher
May 20, 2026

Scienture Holdings (SCNX) Q1 2026 Earnings Surprise: EPS $-0.08, Up SignificantViral Trade Signals - Newser

May 20, 2026
pulisher
May 18, 2026

Scienture Holdings Releases Q1 2026 Financial Results - AlphaStreet

May 18, 2026
pulisher
May 18, 2026

Scienture Holdings, Inc. released its financial results and business progress for the first quarter of 2026. - Bitget

May 18, 2026
pulisher
May 18, 2026

Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady - TradingView

May 18, 2026
pulisher
May 18, 2026

SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion - The Manila Times

May 18, 2026
pulisher
May 18, 2026

SCIENTURE、2026年第1四半期の業績を発表 大幅な収益増と粗利益率拡大が目立つ - Moomoo

May 18, 2026
pulisher
May 18, 2026

Scienture Holdings Secures $11.4 Million Structured Financing Deal - TipRanks

May 18, 2026
pulisher
May 15, 2026

Scienture Holdings (SCNX) Q4 2025 Earnings: EPS $-0.11 Beats EstimatesTrading Community Hub - Newser

May 15, 2026
pulisher
May 15, 2026

Scienture Holdings Inc (FRA:4E4) Stock Price, Trades & News - GuruFocus

May 15, 2026
pulisher
May 15, 2026

Scienture Holdings: Q1 Earnings Snapshot - marketscreener.com

May 15, 2026
pulisher
May 15, 2026

Scienture Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

May 15, 2026
pulisher
May 15, 2026

Scienture Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026
pulisher
May 15, 2026

Number of shareholders of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView

May 15, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 07, 2026

Scienture (SCNX) Secures Patent for Innovative Losartan Suspensi - GuruFocus

May 07, 2026
pulisher
May 07, 2026

Scienture secures $11M debt financing for product launches By Investing.com - Investing.com South Africa

May 07, 2026
pulisher
May 07, 2026

Scienture secures $11M debt financing for product launches - Investing.com UK

May 07, 2026
pulisher
May 07, 2026

Scienture secures $11.0 million in non-dilutive debt financing to accelerate growth of approved product portfolio and advancement of research and development pipeline - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Scienture secures $11 million in non-dilutive debt financing - Investing.com

May 07, 2026
pulisher
May 07, 2026

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - The Manila Times

May 07, 2026
pulisher
May 07, 2026

$11M debt funds Scienture's hypertension drug and overdose spray - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Scienture Holdings Secures $11M Debt Financing Via Note Purchase Agreement >SCNX - Moomoo

May 07, 2026
pulisher
May 07, 2026

Scienture Holdings, Inc. Secures $11 Million in Non-Dilutive Debt Financing - marketscreener.com

May 07, 2026
pulisher
May 06, 2026

Scienture Holdings Issues Updated Investor Presentation Disclosure - The Globe and Mail

May 06, 2026
pulisher
May 06, 2026

Scienture receives third patent for liquid losartan product - Investing.com

May 06, 2026
pulisher
May 06, 2026

Scienture receives third patent for liquid losartan product By Investing.com - Investing.com Australia

May 06, 2026
pulisher
May 06, 2026

SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 - The Manila Times

May 06, 2026
pulisher
May 06, 2026

Scienture secures third patent for ARBLI™ oral suspension, extending market exclusivity to 2041. - Pluang

May 06, 2026
pulisher
May 05, 2026

[8-K] Scienture Holdings, Inc. Reports Material Event - Stock Titan

May 05, 2026
pulisher
May 02, 2026

Scienture Holdings, Inc. Enters $11.42 Million Secured Note Agreement with Streeterville Capital, LLC – April 2026 - Minichart

May 02, 2026
pulisher
May 02, 2026

Scienture Holdings, Inc. 2025 Annual Report: Company Overview, Executive Leadership, and Financial Highlights - Minichart

May 02, 2026
pulisher
May 01, 2026

Scienture Holdings Secures $11.42 Million in Secured Notes Financing From Streeterville Capital - TradingView

May 01, 2026
pulisher
May 01, 2026

Scienture (NASDAQ: SCNX) adds 9% and 5% secured notes with asset pledges - Stock Titan

May 01, 2026
pulisher
Apr 30, 2026

Deep 2025 loss at Scienture (NASDAQ: SCNX) after $26,346,050 impairments - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

MSN Money - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 30, 2026
POM POM
$0.1089
price down icon 11.32%
$1.29
price down icon 9.79%
$2.23
price up icon 5.19%
$2.36
price down icon 1.26%
$3.82
price down icon 7.62%
Kapitalisierung:     |  Volumen (24h):